OCTAPLASLG groupe sanguin 0 sol perf 10 x 200 ml

7680006020092 CH-602 B05AA 06.01.1.
OCTAPLASLG groupe sanguin 0 sol perf 10 x 200 ml
OCTAPLASLG groupe sanguin 0 sol perf 10 x 200 ml
OCTAPLASLG groupe sanguin 0 sol perf 10 x 200 ml
1 / 3
google

Details

Product number
0060201
CPT
-
Packaging group
10x200
Unit
ml
Composition
proteina plasmatis humani 9-14 g, natrii citras dihydricus, natrii dihydrogenophosphas dihydricus, glycinum, aqua ad solutionem pro 200 ml corresp. natrium <40 mmol.

Articles (1)

octaplasLG, Infusionslösung
Infusionslösung
10x200
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
14/01/2025
Professional SmPC
Français
14/01/2025
Professional SmPC
Italien
14/01/2025

Detailed composition

Substance Quantity Type Category
(N/A)
- Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HBESI

Authorization holder

Octapharma AG

8853 Lachen SZ

Authorization information

Swissmedic authorization number
602
Drug name
octaplasLG, Infusionslösung
Galenic form
LSINF
ATC Code
B05AA
Authorization status
Z
Dispensation category
B
First authorization
20/04/1999
Authorization expiration date
31/12/9999
IT number
06.01.1.
Domain
Human medicine
Field of application
komplexe Störungen des Hämostase-Systems ohne Möglichkeit einer differenzierten Therapie, wie z.B. Verbrauchskoagulopatie (DIC)

Packaging details

Description (FR)
OCTAPLASLG groupe sanguin 0 sol perf 10 x 200 ml
Description (DE)
OCTAPLASLG Blutgruppe 0 Inf Lös 10 x 200 ml
Market launch
20/04/1999
Narcotic (BTM)
No

Application methods

IV

Other packaging sizes

OCTAPLASLG groupe sanguin A sol perf 10 x 200 ml
10x200 ML
View
OCTAPLASLG groupe sanguin B sol perf 10 x 200 ml
10x200 ML
View
OCTAPLASLG groupe sanguin AB sol perf 10 x 200 ml
10x200 ML
View